Tivic Health Systems, Inc. TIVC 深 沪
等待开盘 02-06 09:30:00 美东时间
0.8301
-0.121
-12.71%
华盛通- 最 高0.94
- 今 开0.94
- 成交量 7.11万股
- 最 低 0.82
- 昨 收 0.951
- 总市值 209.66万
- 52周最高 13.23
- 市盈率 静 --
- 换手率 2.81%
- 52周最低 0.82
- 委 比 90.88%
- 总股本 252.58万
- 历史最高 11050.00
- 量 比 1.03
- 振 幅 12.62%
- 历史最低 0.82
- 每 手 1
- 风险率 1.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tivic Health Systems Presents Data On Toll-like Receptor 5 Agonist Entolimod
Tivic Health® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that it delivered an invited presentation at a TechWatch meeting with the Biomedical Advanced Research and
01-28 21:33
Tivic Health Systems Delivers 200x Scale-Up In Manufacturing Volume For Lead Drug Candidate Entolimod
Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS) and Neutropenia through wholly owned contract development manufacturing organization (CDMO),
01-12 22:03
Why Davis Commodities Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
Shares of Davis Commodities Ltd (NASDAQ:DTCK) rose sharply in pre-market tradin...
2025-12-26 17:40
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Trinity Biotech (NASDAQ:TRIB) stock moved upwards by 54.7% to $1.38 du...
2025-12-24 01:05
Tivic Health Acquires Strategic Manufacturing And Development Assets Of Scorpius Holdings; Launches Velocity Bioworks Subsidiary; Secures $16M Debt, Up To $75M Preferred Equity, And $50M Credit Line from 3i, LP
Acquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization (CDMO) subsidiary, Velocity Bioworks™Financing led by 3i, LP includes $16M debt
2025-12-11 22:51
Tivic Health Systems Secures Techwatch Meeting With Biomedical Advanced Research and Development Authority's Radiological and Nuclear Medical Countermeasures Program Staff For for Acute Radiation Syndrome
Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage therapeutics company, today announced it has secured an exclusive Techwatch meeting with the Biomedical Advanced Research and Development Authority (BARDA)'s
2025-11-18 21:35
Tivic Health Systems Q3 EPS $(2.00) Up From $(3.93) YoY, Sales $146.000K Up From $126.000K YoY
Tivic Health Systems (NASDAQ:TIVC) reported quarterly losses of $(2.00) per share. This is a 49.11 percent increase over losses of $(3.93) per share from the same period last year. The company reported $146.000 thousand
2025-11-15 05:49
Earnings Scheduled For November 14, 2025
Companies Reporting Before The Bell • Inhibrx Biosciences (NASDAQ:INBX) is expe...
2025-11-14 19:11
Tivic Health Systems Announces New CEO Employment Agreement
Tivic Health Systems ( ($TIVC) ) has provided an announcement. On October 8, 20...
2025-10-16 05:18
Tivic Health Systems Completes Entolimod Cell Line Verification, Advancing CGMP In Preparation For Biologics License Application
Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced that it has completed verification of its Entolimod™ cell line, the first step in establishing Current Good
2025-09-10 20:41
